Cargando…

Tauroursodeoxycholic Acid Attenuates Renal Tubular Injury in a Mouse Model of Type 2 Diabetes

Renal tubular injury is a critical factor in the pathogenesis of diabetic nephropathy (DN). Endoplasmic reticulum (ER) stress is involved in diabetic nephropathy. Tauroursodeoxycholic acid (TUDCA) is an effective inhibitor of ER stress. Here, we investigated the role of TUDCA in the progression of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jing, Fan, Ying, Zeng, Chuchu, He, Li, Wang, Niansong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083977/ https://www.ncbi.nlm.nih.gov/pubmed/27669287 http://dx.doi.org/10.3390/nu8100589

Ejemplares similares

Endoplasmic Reticulum Chaperon Tauroursodeoxycholic Acid Attenuates Aldosterone-Infused Renal Injury
por: Guo, Honglei, et al.
Publicado: (2016)

Administration of Tauroursodeoxycholic Acid Attenuates Early Brain Injury via Akt Pathway Activation
por: Sun, Dongdong, et al.
Publicado: (2017)

Tauroursodeoxycholic Acid Protects Retinal and Visual Function in a Mouse Model of Type 1 Diabetes
por: Fu, Jieming, et al.
Publicado: (2021)

Tauroursodeoxycholic acid attenuates endoplasmic reticulum stress and protects the liver from chronic intermittent hypoxia induced injury
por: Hou, Yanpeng, et al.
Publicado: (2017)

MYCT1 attenuates renal fibrosis and tubular injury in diabetic kidney disease
por: Li, Xin, et al.
Publicado: (2023)

Effects of Tauroursodeoxycholic Acid and 4-Phenylbutyric Acid on Selenium Distribution in Mice Model with Type 1 Diabetes
por: Xing, Dongyang, et al.
Publicado: (2022)

Therapeutic Potential of Tauroursodeoxycholic Acid for the Treatment of Osteoporosis
por: Ahn, Tae-Keun, et al.
Publicado: (2020)

Formononetin Attenuates Renal Tubular Injury and Mitochondrial Damage in Diabetic Nephropathy Partly via Regulating Sirt1/PGC-1α Pathway
por: Huang, Qunwei, et al.
Publicado: (2022)

Prevention of Acute Kidney Injury by Tauroursodeoxycholic Acid in Rat and Cell Culture Models
por: Gupta, Sandeep, et al.
Publicado: (2012)

Effect of Tauroursodeoxycholic Acid and 4-Phenylbutyric Acid on Metabolism of Copper and Zinc in Type 1 Diabetic Mice Model
por: Zhou, Qi, et al.
Publicado: (2015)

Correction to: Effects of Tauroursodeoxycholic Acid and 4-Phenylbutyric Acid on Selenium Distribution in Mice Model with Type 1 Diabetes
por: Xing, Dongyang, et al.
Publicado: (2023)

Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis
por: Elia, A. E., et al.
Publicado: (2015)

Effect of 4-Phenylbutyric Acid and Tauroursodeoxycholic Acid on Magnesium and Calcium Metabolism in Streptozocin-Induced Type 1 Diabetic Mice
por: Zhou, Qi, et al.
Publicado: (2018)

Tauroursodeoxycholic acid (TUDCA) attenuates pressure overload-induced cardiac remodeling by reducing endoplasmic reticulum stress
por: Rani, Shilpa, et al.
Publicado: (2017)

Increased Serum Uric Acid Level Is a Risk Factor for Left Ventricular Hypertrophy but Not Independent of eGFR in Patients with Type 2 Diabetic Kidney Disease
por: Zeng, Chuchu, et al.
Publicado: (2017)

Tauroursodeoxycholic Acid Protects Retinal Pigment Epithelial Cells from Oxidative Injury and Endoplasmic Reticulum Stress In Vitro
por: Alhasani, Reem Hasaballah, et al.
Publicado: (2020)

Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases
por: Khalaf, Kareem, et al.
Publicado: (2022)

Tauroursodeoxycholic Acid Inhibits Clostridioides difficile Toxin-Induced Apoptosis
por: Pike, Colleen M., et al.
Publicado: (2022)

Effect of Tauroursodeoxycholic Acid on Inflammation after Ocular Alkali Burn
por: Huang, Yanqiao, et al.
Publicado: (2022)

Mechanisms of tauroursodeoxycholate-mediated inhibition of apoptosis
por: Sommerfeld, Annika, et al.
Publicado: (2014)

Ursodeoxycholic Acid but Not Tauroursodeoxycholic Acid Inhibits Proliferation and Differentiation of Human Subcutaneous Adipocytes
por: Mališová, Lucia, et al.
Publicado: (2013)

Review: The bile acids urso- and tauroursodeoxycholic acid as neuroprotective therapies in retinal disease
por: Daruich, Alejandra, et al.
Publicado: (2019)

Bilirubin attenuates the renal tubular injury by inhibition of oxidative stress and apoptosis
por: Oh, Se Won, et al.
Publicado: (2013)

Tauroursodeoxycholic acid attenuates neuronal apoptosis via the TGR5/ SIRT3 pathway after subarachnoid hemorrhage in rats
por: Wu, Huihui, et al.
Publicado: (2020)

The Unexpected Uses of Urso- and Tauroursodeoxycholic Acid in the Treatment of Non-liver Diseases
por: Vang, Sheila, et al.
Publicado: (2014)

Tauroursodeoxycholic acid: more than just a neuroprotective bile conjugate
por: Romero-Ramírez, Lorenzo, et al.
Publicado: (2017)

Metabolomics and Lipidomics Study Unveils the Impact of Tauroursodeoxycholic Acid on Hyperlipidemic Mice
por: Cui, Na, et al.
Publicado: (2023)

Wnt5a promotes renal tubular inflammation in diabetic nephropathy by binding to CD146 through noncanonical Wnt signaling
por: Li, Xiaomei, et al.
Publicado: (2021)

Interleukin-22 Attenuated Renal Tubular Injury in Aristolochic Acid Nephropathy via Suppressing Activation of NLRP3 Inflammasome
por: Wang, Shaofei, et al.
Publicado: (2019)

Tauroursodeoxycholic acid alleviates secondary injury in spinal cord injury mice by reducing oxidative stress, apoptosis, and inflammatory response
por: Hou, Yonghui, et al.
Publicado: (2021)

Tubular Overexpression of Angiopoietin-1 Attenuates Renal Fibrosis
por: Singh, Sudhir, et al.
Publicado: (2016)

Tauroursodeoxycholic Acid Reduces Neuroinflammation but Does Not Support Long Term Functional Recovery of Rats with Spinal Cord Injury
por: Wu, Siyu, et al.
Publicado: (2022)

Tauroursodeoxycholic acid reduces glial cell activation in an animal model of acute neuroinflammation
por: Yanguas-Casás, Natalia, et al.
Publicado: (2014)

Tauroursodeoxycholic acid mediates endoplasmic reticulum stress and autophagy in adrenocortical carcinoma cells
por: Huang, Xuemei, et al.
Publicado: (2019)

Tauroursodeoxycholate—Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives
por: Kusaczuk, Magdalena
Publicado: (2019)

Comparative Analysis of Urso- and Tauroursodeoxycholic Acid Neuroprotective Effects on Retinal Degeneration Models
por: Daruich, Alejandra, et al.
Publicado: (2022)

Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol
por: Albanese, Alberto, et al.
Publicado: (2022)

Effects of oral tauroursodeoxycholic acid and/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis
por: Gao, Fan, et al.
Publicado: (2022)

Tauroursodeoxycholic acid inhibits TGF-β1-induced renal fibrosis markers in cultured renal mesangial cells by regulating endoplasmic reticulum stress
por: Li, Li, et al.
Publicado: (2022)

Preparation and toxicity evaluation of a novel nattokinase-tauroursodeoxycholate complex
por: Feng, Rui, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tl1r7bvtbmjjg9cio7b25qn6pp